FDA Says Diabetes Drugs Onglyza, Nesina May Increase Heart Failure Risk
(April 6, 2016, 11:20 AM EDT) -- SILVER SPRING, Md. — The diabetes drugs Onglyza and Nesina may increase the risk of heart failure, particularly in patients who already have heart or kidney disease, the Food and Drug Administration said April 5....